{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:55:49Z","timestamp":1791932149028,"version":"4.3.4"},"reference-count":43,"publisher":"The Endocrine Society","issue":"6","funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["Z01 DK011006"],"award-info":[{"award-number":["Z01 DK011006"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,6,1]]},"DOI":"10.1210\/en.2019-00055","type":"journal-article","created":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T17:39:58Z","timestamp":1558373998000},"page":"1468-1479","source":"Crossref","is-referenced-by-count":55,"title":["Arrestin-\u03b2-1 Physically Scaffolds TSH and IGF1 Receptors to Enable Crosstalk"],"prefix":"10.1210","volume":"160","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1856-415X","authenticated-orcid":false,"given":"Christine C","family":"Krieger","sequence":"first","affiliation":[{"name":"Laboratory of Endocrinology and Receptor Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisa","family":"Boutin","sequence":"additional","affiliation":[{"name":"Laboratory of Endocrinology and Receptor Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daesong","family":"Jang","sequence":"additional","affiliation":[{"name":"Laboratory of Endocrinology and Receptor Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah J","family":"Morgan","sequence":"additional","affiliation":[{"name":"Laboratory of Endocrinology and Receptor Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Paul","family":"Banga","sequence":"additional","affiliation":[{"name":"Faculty of Life Sciences & Medicine, King\u2019s College London, The Rayne Institute, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George J","family":"Kahaly","sequence":"additional","affiliation":[{"name":"Molecular Thyroid Research Laboratory, Department of Medicine I, Johannes Gutenberg University Medical Center, Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Klubo-Gwiezdzinska","sequence":"additional","affiliation":[{"name":"Metabolic Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Neumann","sequence":"additional","affiliation":[{"name":"Laboratory of Endocrinology and Receptor Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marvin C","family":"Gershengorn","sequence":"additional","affiliation":[{"name":"Laboratory of Endocrinology and Receptor Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2019,4,26]]},"reference":[{"issue":"8","key":"2019052810101906200_bib1","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1056\/NEJMra0905750","article-title":"Graves\u2019 ophthalmopathy","volume":"362","author":"Bahn","year":"2010","journal-title":"N Engl J Med"},{"issue":"10","key":"2019052810101906200_bib2","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1055\/s-0035-1555762","article-title":"Current insights into the pathogenesis of Graves\u2019 ophthalmopathy","volume":"47","author":"Bahn","year":"2015","journal-title":"Horm Metab Res"},{"key":"2019052810101906200_bib3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.exer.2015.02.007","article-title":"Current perspectives on the role of orbital fibroblasts in the pathogenesis of Graves\u2019 ophthalmopathy","volume":"142","author":"Dik","year":"2016","journal-title":"Exp Eye Res"},{"issue":"3","key":"2019052810101906200_bib4","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1210\/jc.2014-3566","article-title":"Bidirectional TSH and IGF-1 receptor cross talk mediates stimulation of hyaluronan secretion by Graves\u2019 disease immunoglobins","volume":"100","author":"Krieger","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2019052810101906200_bib5","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1210\/jc.2011-2890","article-title":"A stimulatory thyrotropin receptor antibody enhances hyaluronic acid synthesis in graves\u2019 orbital fibroblasts: inhibition by an IGF-I receptor blocking antibody","volume":"97","author":"Kumar","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2019052810101906200_bib6","doi-asserted-by":"crossref","first-page":"5076","DOI":"10.1210\/jc.2004-0716","article-title":"Immunoglobulins from patients with Graves\u2019 disease induce hyaluronan synthesis in their orbital fibroblasts through the self-antigen, insulin-like growth factor-I receptor","volume":"89","author":"Smith","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2019052810101906200_bib7","doi-asserted-by":"crossref","first-page":"E1183","DOI":"10.1210\/jc.2013-4182","article-title":"Possible targets for nonimmunosuppressive therapy of Graves\u2019 orbitopathy","volume":"99","author":"Zhang","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2019052810101906200_bib8","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1210\/jc.2016-1315","article-title":"TSH\/IGF-1 receptor cross talk in Graves\u2019 ophthalmopathy pathogenesis","volume":"101","author":"Krieger","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2019052810101906200_bib9","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1210\/en.2017-00528","article-title":"TSH\/IGF-1 receptor cross-talk rapidly activates extracellular signal-regulated kinases in multiple cell types","volume":"158","author":"Krieger","year":"2017","journal-title":"Endocrinology"},{"issue":"22","key":"2019052810101906200_bib10","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1038\/sj.onc.1210407","article-title":"G protein regulation of MAPK networks","volume":"26","author":"Goldsmith","year":"2007","journal-title":"Oncogene"},{"issue":"5721","key":"2019052810101906200_bib11","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1126\/science.1109237","article-title":"Transduction of receptor signals by beta-arrestins","volume":"308","author":"Lefkowitz","year":"2005","journal-title":"Science"},{"issue":"8","key":"2019052810101906200_bib12","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1096\/fj.14-251124","article-title":"\u03b2-Arrestin-1 mediates thyrotropin-enhanced osteoblast differentiation","volume":"28","author":"Boutin","year":"2014","journal-title":"FASEB J"},{"issue":"51","key":"2019052810101906200_bib13","doi-asserted-by":"crossref","first-page":"51334","DOI":"10.1074\/jbc.M309968200","article-title":"Beta-arrestin1 mediates insulin-like growth factor 1 (IGF-1) activation of phosphatidylinositol 3-kinase (PI3K) and anti-apoptosis","volume":"278","author":"Povsic","year":"2003","journal-title":"J Biol Chem"},{"issue":"41","key":"2019052810101906200_bib14","doi-asserted-by":"crossref","first-page":"5734","DOI":"10.1038\/onc.2017.179","article-title":"Functional antagonism of \u03b2-arrestin isoforms balance IGF-1R expression and signalling with distinct cancer-related biological outcomes","volume":"36","author":"Suleymanova","year":"2017","journal-title":"Oncogene"},{"issue":"47","key":"2019052810101906200_bib15","doi-asserted-by":"crossref","first-page":"82256","DOI":"10.18632\/oncotarget.19286","article-title":"Enhanced response of melanoma cells to MEK inhibitors following unbiased IGF-1R down-regulation","volume":"8","author":"Suleymanova","year":"2017","journal-title":"Oncotarget"},{"issue":"50","key":"2019052810101906200_bib16","doi-asserted-by":"crossref","first-page":"20620","DOI":"10.1073\/pnas.1216348110","article-title":"\u03b2-Arrestin-biased agonism as the central mechanism of action for insulin-like growth factor 1 receptor-targeting antibodies in Ewing\u2019s sarcoma","volume":"109","author":"Zheng","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"48","key":"2019052810101906200_bib17","doi-asserted-by":"crossref","first-page":"31640","DOI":"10.1074\/jbc.273.48.31640","article-title":"beta-Arrestins regulate mitogenic signaling and clathrin-mediated endocytosis of the insulin-like growth factor I receptor","volume":"273","author":"Lin","year":"1998","journal-title":"J Biol Chem"},{"issue":"22","key":"2019052810101906200_bib18","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1038\/sj.onc.1210394","article-title":"Integrating signals from RTKs to ERK\/MAPK","volume":"26","author":"McKay","year":"2007","journal-title":"Oncogene"},{"issue":"12","key":"2019052810101906200_bib19","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.tips.2007.09.007","article-title":"GPCR-jacking: from a new route in RTK signalling to a new concept in GPCR activation","volume":"28","author":"Delcourt","year":"2007","journal-title":"Trends Pharmacol Sci"},{"issue":"9","key":"2019052810101906200_bib20","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1158\/1078-0432.CCR-09-2229","article-title":"Crosstalk between insulin\/insulin-like growth factor-1 receptors and G protein-coupled receptor signaling systems: a novel target for the antidiabetic drug metformin in pancreatic cancer","volume":"16","author":"Rozengurt","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"8","key":"2019052810101906200_bib21","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.tips.2011.04.002","article-title":"Receptor tyrosine kinase-G-protein-coupled receptor signalling platforms: out of the shadow","volume":"32","author":"Pyne","year":"2011","journal-title":"Trends Pharmacol Sci"},{"issue":"6","key":"2019052810101906200_bib22","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.4049\/jimmunol.181.6.4397","article-title":"Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves\u2019 disease","volume":"181","author":"Tsui","year":"2008","journal-title":"J Immunol"},{"issue":"4","key":"2019052810101906200_bib23","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/bph.13693","article-title":"Inhibiting thyrotropin\/insulin-like growth factor 1 receptor crosstalk to treat Graves\u2019 ophthalmopathy: studies in orbital fibroblasts in vitro","volume":"174","author":"Place","year":"2017","journal-title":"Br J Pharmacol"},{"issue":"10","key":"2019052810101906200_bib24","doi-asserted-by":"crossref","first-page":"7203","DOI":"10.1128\/MCB.19.10.7203","article-title":"Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis","volume":"19","author":"Peruzzi","year":"1999","journal-title":"Mol Cell Biol"},{"issue":"Pt 2","key":"2019052810101906200_bib25","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1042\/BJ20050216","article-title":"Grb10 and Grb14: enigmatic regulators of insulin action--and more","volume":"388","author":"Holt","year":"2005","journal-title":"Biochem J"},{"issue":"5","key":"2019052810101906200_bib26","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1089\/thy.2017.0105","article-title":"TSHR\/IGF-1R cross-talk, not IGF-1R stimulating antibodies, mediates Graves\u2019 ophthalmopathy pathogenesis","volume":"27","author":"Krieger","year":"2017","journal-title":"Thyroid"},{"issue":"5","key":"2019052810101906200_bib27","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1089\/thy.2018.0089","article-title":"Evidence that graves\u2019 ophthalmopathy immunoglobulins do not directly activate IGF-1 receptors","volume":"28","author":"Marcus-Samuels","year":"2018","journal-title":"Thyroid"},{"issue":"8","key":"2019052810101906200_bib28","doi-asserted-by":"crossref","first-page":"5084","DOI":"10.4049\/jimmunol.176.8.5084","article-title":"Monoclonal pathogenic antibodies to the thyroid-stimulating hormone receptor in Graves\u2019 disease with potent thyroid-stimulating activity but differential blocking activity activate multiple signaling pathways","volume":"176","author":"Gilbert","year":"2006","journal-title":"J Immunol"},{"key":"2019052810101906200_bib29","unstructured":"RRID:\n          AB_2800394, https:\/\/scicrunch.org\/resolver\/RRID:AB_2800394."},{"key":"2019052810101906200_bib30","unstructured":"RRID:\n          AB_2630358, https:\/\/scicrunch.org\/resolver\/RRID:AB_2630358."},{"key":"2019052810101906200_bib31","unstructured":"RRID:\n          AB_443526, https:\/\/scicrunch.org\/resolver\/RRID:AB_443526."},{"key":"2019052810101906200_bib32","unstructured":"RRID:\n          AB_331768, https:\/\/scicrunch.org\/resolver\/RRID:AB_331768."},{"key":"2019052810101906200_bib33","unstructured":"RRID:\n          AB_2800395, https:\/\/scicrunch.org\/resolver\/RRID:AB_2800395."},{"issue":"1","key":"2019052810101906200_bib34","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000443828","article-title":"The 2016 European Thyroid Association\/European Group on Graves\u2019 Orbitopathy guidelines for the management of Graves\u2019 orbitopathy","volume":"5","author":"Bartalena","year":"2016","journal-title":"Eur Thyroid J"},{"key":"2019052810101906200_bib35","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/978-1-4939-2742-5_15","article-title":"In situ proximity ligation assay (PLA)","volume":"1318","author":"Bagchi","year":"2015","journal-title":"Methods Mol Biol"},{"issue":"2","key":"2019052810101906200_bib36","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2144\/000113354","article-title":"A proximity ligation assay using transiently transfected, epitope-tagged proteins: application for in situ detection of dimerized receptor tyrosine kinases","volume":"48","author":"Gajadhar","year":"2010","journal-title":"Biotechniques"},{"issue":"119","key":"2019052810101906200_bib37","first-page":"e55218","article-title":"Visualization of protein-protein interaction in nuclear and cytoplasmic fractions by co-immunoprecipitation and in situ proximity ligation assay","volume":"2017","author":"Zhu","journal-title":"J Vis Exp"},{"issue":"12","key":"2019052810101906200_bib38","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1089\/thy.2016.0323","article-title":"Thyrotropin and insulin-like growth factor 1 receptor crosstalk upregulates sodium-iodide symporter expression in primary cultures of human thyrocytes","volume":"26","author":"Morgan","year":"2016","journal-title":"Thyroid"},{"issue":"6","key":"2019052810101906200_bib39","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1210\/en.2005-0687","article-title":"The human thyrotropin receptor is predominantly internalized by beta-arrestin 2","volume":"147","author":"Frenzel","year":"2006","journal-title":"Endocrinology"},{"issue":"18","key":"2019052810101906200_bib40","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1056\/NEJMoa1614949","article-title":"Teprotumumab for thyroid-associated ophthalmopathy","volume":"376","author":"Smith","year":"2017","journal-title":"N Engl J Med"},{"issue":"7","key":"2019052810101906200_bib41","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.tibs.2018.04.003","article-title":"Emerging paradigm of intracellular targeting of G protein-coupled receptors","volume":"43","author":"Chaturvedi","year":"2018","journal-title":"Trends Biochem Sci"},{"issue":"3","key":"2019052810101906200_bib42","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1124\/pr.116.013367","article-title":"The diverse roles of arrestin scaffolds in G protein-coupled receptor signaling","volume":"69","author":"Peterson","year":"2017","journal-title":"Pharmacol Rev"},{"issue":"10","key":"2019052810101906200_bib43","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.tips.2018.08.003","article-title":"Therapeutic targeting of endosomal G-protein-coupled receptors","volume":"39","author":"Thomsen","year":"2018","journal-title":"Trends Pharmacol Sci"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/advance-article-pdf\/doi\/10.1210\/en.2019-00055\/28521135\/en.2019-00055.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/160\/6\/1468\/28708601\/en.2019-00055.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T10:10:44Z","timestamp":1559038244000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/160\/6\/1468\/5479346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,26]]},"references-count":43,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,4,26]]},"published-print":{"date-parts":[[2019,6,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2019-00055","relation":{},"ISSN":["1945-7170"],"issn-type":[{"value":"1945-7170","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,6]]},"published":{"date-parts":[[2019,4,26]]}}}